A lipid nanoparticle is assembled around a cargo, and the cargo defines most of the constraints that govern a workable formulation. Messenger RNA must be condensed electrostatically inside an acidic core and then released into the cytosol after endosomal maturation. A short, rigid small interfering RNA duplex has a different charge density and a different folding geometry. A protein, in contrast, carries no reproducible negative charge and must be retained in the particle by interfacial interactions rather than electrostatic complexation. A hydrophobic small molecule partitions into the lipid bilayer itself. Because each payload engages the nanoparticle through a different mechanism, the ionizable lipid, helper lipid, cholesterol, and PEG-lipid composition that performs well for one cargo can fail outright for another.
A payload-specific lipid library screening program treats the lipid components as tunable variables that are varied systematically around a defined cargo. Instead of re-optimizing one formulation from scratch for every project, a well-constructed library lets a research team probe many lipid structures and compositions in parallel, rank them with a consistent set of readouts, and select a lead that is already matched to the physicochemical demands of the payload. The practical benefit is not merely more candidates, but more informative ones, because each library member is designed to answer a specific question about how lipid structure affects delivery for that particular cargo.
An LNP lipid library should not contain only one representative molecule for each lipid component. For meaningful payload-specific screening, each component should be represented by a sub-library of individual lipid molecules that covers a sufficiently broad but interpretable chemical space. The purpose is to expose the payload to systematic differences in headgroup chemistry, linker type, hydrophobic chain length, branching, saturation, sterol substitution, PEG length, and lipid-anchor structure. If the library contains only closely related molecules, a potentially important structure-performance relationship may never be tested.
A practical library should therefore be built along defined structural gradients. For example, an ionizable lipid set can span C10-C18 hydrophobic tails and several ionizable headgroup families; a helper-lipid set can compare C14-C18 phospholipid chains together with saturated and unsaturated structures; a sterol set can progressively vary C24 substitution and side-chain unsaturation; and a PEG-lipid set can combine C14-C18 anchors with PEG chains from approximately 1 to 5 kDa. The exact number of molecules can be adjusted to project scale, but the structural range should remain sufficiently broad to avoid screening only a narrow region of lipid chemical space.
Ionizable lipids usually require the broadest molecular diversity because several parts of the molecule can independently affect payload association, particle assembly, membrane interaction, and intracellular release. A useful ionizable lipid screening set should therefore contain molecules that systematically vary the hydrophilic head, linker, and hydrophobic domain rather than many analogs differing at only one minor position.
The core library can be organized around the following structural dimensions:
Table 1. Suggested Structural Coverage for an Ionizable Lipid Sub-Library.
| Structural Variable | Suggested Range or Classes | Representative Examples | Why Include the Range? |
| Ionizable Headgroup | Multiple linear and cyclic amine families | Dimethylamino, diethylamino, amino alcohol, piperidine, piperazine, imidazole, polyamine | Expands ionization behavior and headgroup geometry rather than testing only one amine family |
| Linker | Stable and degradable linker classes | Ester, amide, carbonate, carbamate, ether, disulfide | Changes molecular flexibility, stability, and degradation behavior |
| Tail Length | Approximately C10-C18 | C10, C12, C14, C16, C18 | Provides a broad hydrophobicity and packing range |
| Tail Number | 2-4 hydrophobic chains | Two-tail, three-tail, four-tail structures | Changes molecular geometry and lipid packing |
| Branching | Linear to branched | Linear, α-branched, terminal-branched | Tests the effect of steric bulk and packing disorder |
| Unsaturation | Saturated to unsaturated | Saturated, mono-unsaturated, selected multi-unsaturated tails | Broadens membrane fluidity and packing characteristics |
| Symmetry | Symmetric and asymmetric | Equal-length vs. mixed-length tails | Tests whether uneven hydrophobic architecture benefits the payload |
Rather than filling the library with many closely related C12 or C14 analogs, the first-pass set should deliberately cross several of these dimensions. Once a favorable headgroup or tail family emerges, a second-generation library can narrow the structural spacing and investigate smaller changes around the lead chemistry.
A helper-lipid sub-library can be smaller than an ionizable lipid library, but it should still cover distinct phospholipid structures. The clearest way to build this set is to control one molecular feature while varying another. For example, a homologous phosphatidylcholine series can change acyl-chain length while keeping the headgroup constant, and a second series can introduce unsaturation or a phosphatidylethanolamine headgroup. This makes the results easier to interpret than comparing a small number of structurally unrelated helper lipids.
For LNP helper lipid screening, a useful core range can include:
Table 2. Representative Helper Lipids for Building a Structurally Diverse Library.
| Helper Lipid | Headgroup | Acyl Chains | Structural Feature Represented |
| DMPC | PC | 14:0 / 14:0 | Shorter saturated PC |
| DPPC | PC | 16:0 / 16:0 | Intermediate saturated PC |
| DSPC | PC | 18:0 / 18:0 | Longer saturated PC |
| POPC | PC | 16:0 / 18:1 | Asymmetric, partially unsaturated PC |
| SOPC | PC | 18:0 / 18:1 | C18 mixed-saturation PC |
| DOPC | PC | 18:1 / 18:1 | Fully unsaturated PC |
| DSPE | PE | 18:0 / 18:0 | Saturated PE comparator |
| DOPE | PE | 18:1 / 18:1 | Unsaturated PE with different packing geometry |
This type of set gives the library several independent comparisons: C14 vs. C16 vs. C18 chain length, saturated vs. unsaturated tails, symmetric vs. asymmetric tails, and PC vs. PE headgroups. A helper-lipid library containing only DSPC and DOPE can reveal a large structural contrast, but it cannot show where the optimum lies between those two extremes.
The sterol sub-library should also contain individual molecules selected according to defined structural differences. Cholesterol is a useful reference, but screening only cholesterol against one unrelated analog provides limited information. A more informative sterol screening strategy progressively modifies side-chain substitution, unsaturation, and sterol rigidity while retaining the common sterol framework.
A practical core series can begin with cholesterol, campesterol, and β-sitosterol. These molecules progressively change substitution around the C24 region of the side chain. The library can then add stigmasterol, stigmastanol, fucosterol, or ergosterol-type structures to broaden side-chain unsaturation and sterol-body rigidity.
Table 3. Representative Sterols for Expanding LNP Sterol Chemical Space.
| Sterol | Key Structural Feature | Library Role |
| Cholesterol | Reference sterol without an additional C24 alkyl substituent | Baseline for comparing sterol variants |
| Campesterol | C24 methyl substitution | Introduces a small increase in side-chain steric bulk |
| β-Sitosterol | C24 ethyl substitution | Extends the C24 alkyl substitution series |
| Stigmasterol | C24 ethyl substitution with additional side-chain unsaturation | Tests the combined effect of side-chain size and unsaturation |
| Stigmastanol | More saturated sterol framework relative to corresponding unsaturated sterols | Expands sterol saturation and molecular-rigidity space |
| Fucosterol | Unsaturated C24 ethylidene-type side chain | Introduces a distinct bulky, unsaturated side-chain architecture |
| Ergosterol | Additional unsaturation in the sterol body and side chain | Extends the library toward more rigid, unsaturated sterol structures |
A useful sterol set should therefore contain more than arbitrary cholesterol derivatives. It should provide a recognizable progression from cholesterol to C24-methyl and C24-ethyl analogs, followed by molecules that alter side-chain unsaturation or sterol rigidity. This structured selection makes it possible to determine whether the payload responds to steric bulk, molecular flexibility, or another sterol-dependent packing feature.
PEG-lipids should be treated as individual lipid molecules with two independently tunable structural regions: the hydrophobic anchor and the PEG chain. PEG-lipid molar percentage is a formulation variable and should be optimized later; at the molecular-library stage, the priority is to include PEG-lipids whose anchors and polymer chains span enough structural space to identify an appropriate molecule.
For PEG-lipid screening, the core anchor-length range can cover approximately C14-C18. Representative phospholipid anchors include DMPE-PEG (C14), DPPE-PEG (C16), DSPE-PEG (C18:0), and DOPE-PEG (C18:1), while diglyceride-type anchors such as DMG-PEG (C14) and DSG-PEG (C18) add a second anchor class. Combining these structures helps distinguish the effect of chain length from the effect of the anchor backbone itself.
PEG molecular weight should also span multiple lengths rather than relying exclusively on PEG2000. A practical screening series can include PEG1000, PEG2000, PEG3000 or PEG3400, and PEG5000. The same anchor can be paired with several PEG lengths to generate a controlled polymer-length series. For example, a C14 anchor series containing C14-PEG1000, C14-PEG2000, C14-PEG3000, and C14-PEG5000 allows PEG-chain effects to be evaluated without simultaneously changing the hydrophobic anchor.
Table 4. Suggested Molecular Coverage for a PEG-Lipid Sub-Library.
| Structural Variable | Recommended Coverage | Representative PEG-Lipids or Modifications |
| Anchor Chain Length | C14-C18 core range | DMPE-PEG / DMG-PEG (C14), DPPE-PEG (C16), DSPE-PEG / DSG-PEG (C18) |
| Anchor Saturation | Saturated and unsaturated C18 structures | DSPE-PEG (18:0/18:0) vs. DOPE-PEG (18:1/18:1) |
| Anchor Class | Phospholipid and diglyceride anchors | DMPE-PEG / DSPE-PEG vs. DMG-PEG / DSG-PEG |
| PEG Molecular Weight | Approximately 1-5 kDa | PEG1000, PEG2000, PEG3000/3400, PEG5000 |
| Terminal Functionality | Nonreactive and conjugation-ready termini | Methoxy, NH2, COOH, maleimide, azide, or other click-ready groups |
Terminal functionality does not need to be extensively diversified when the goal is a conventional non-targeted LNP; a methoxy-terminated PEG-lipid can serve as the primary reference. NH2, COOH, maleimide, azide, or other conjugation-ready termini become more relevant when the future formulation will carry peptides, antibodies, glycans, or other targeting ligands. In these cases, the functional group should be incorporated as a defined sub-library rather than mixed indiscriminately with the initial PEG-length screen.
Taken together, a useful LNP lipid library should provide meaningful structural breadth within all four component classes. Ionizable lipids require the widest variation in headgroup, linker, and hydrophobic architecture; helper lipids should span chain length, headgroup, saturation, and symmetry; sterols should cover progressive side-chain substitutions and unsaturation; and PEG-lipids should vary anchor architecture and PEG length. The goal is not to include every possible lipid molecule, but to avoid leaving major regions of chemical space unexplored before payload-specific screening begins.
Table 5. Recommended Structural Coverage for a Focused LNP Lipid Library.
| Lipid Sub-Library | Core Structural Range to Cover | Representative Molecules or Structures | What a Narrow Library May Miss |
| Ionizable Lipids | Multiple headgroups and linkers; C10-C18 tails; linear/branched; saturated/unsaturated; symmetric/asymmetric | Tertiary amine, amino alcohol, piperidine, piperazine, imidazole; C10, C12, C14, C16, C18 tails | Payload-specific effects of ionization, hydrophobicity, branching, and molecular geometry |
| Helper Lipids | PC and PE; core C14-C18 chains; saturated, mixed, and unsaturated structures | DMPC, DPPC, DSPC, POPC, SOPC, DOPC, DSPE, DOPE | Optimal membrane packing between highly rigid and highly fluid helper lipids |
| Sterols | C24 substitution, side-chain size, unsaturation, and sterol rigidity | Cholesterol, campesterol, β-sitosterol, stigmasterol, stigmastanol, fucosterol, ergosterol | Potential improvements caused by subtle sterol side-chain or rigidity changes |
| PEG-Lipids | C14-C18 anchors; phospholipid/diglyceride anchors; PEG1k-5k; saturated/unsaturated anchors | DMPE-PEG, DPPE-PEG, DSPE-PEG, DOPE-PEG, DMG-PEG, DSG-PEG | The appropriate balance between anchor retention, polymer length, and surface presentation |
BOC Sciences can help define the structural space of ionizable lipids, helper lipids, sterols, and PEG-lipids according to your payload and screening objectives, and build a focused library with sufficient molecular diversity for meaningful candidate selection.
The same four component axes are weighted differently depending on the cargo. The tables below translate the physicochemical demands of each payload class into the best-guess combination of ionizable lipid, helper lipid, sterol, and PEG-lipid, together with the reason that combination is favored. These recommended windows are a rational starting point for a screen, not a substitute for testing a spread of compositions.
Messenger RNA is large, single-stranded, and flexible, and its many anionic groups make electrostatic complexation easy. The limiting steps are protecting the message, escaping the endosome, and delivering a translatable message. The ionizable lipid head group and pKa are therefore the dominant variables, and fusogenicity often matters more than bilayer rigidity.
| Component | Recommended Combination | Reason |
|---|---|---|
| Ionizable lipid | Head group with an apparent pKa of about 6.2-6.6 | Neutral at physiological pH, protonated in the endosome to drive membrane destabilization and cytosolic release of the message |
| Helper lipid | Fusogenic, cone-shaped lipid such as DOPE | Promotes the membrane fusion and curvature needed for efficient endosomal escape |
| Cholesterol / sterol | Moderate cholesterol content (roughly 30-40 mol%) | Stabilizes the particle and maintains bilayer fluidity for a large, flexible cargo |
| PEG-lipid | Low molar content, short-to-medium anchor | Preserves a small, uniform particle and allows the protective layer to shed for cellular uptake |
Self-amplifying RNA is considerably longer than mRNA because it encodes its own replicase machinery. The larger message presents a higher electrostatic demand and greater sensitivity to damage, so the emphasis shifts to robust complexation and strong payload protection while still allowing functional translation.
| Component | Recommended Combination | Reason |
|---|---|---|
| Ionizable lipid | Higher-charge-density head groups with strong complexation capacity | Condenses a very long polynucleotide and protects it against nuclease damage |
| Helper lipid | Balanced rigidity and fusogenicity | Protects the long message while still supporting the escape required for replicase translation |
| Cholesterol / sterol | Adequate sterol to stabilize the larger core | Maintains particle cohesion when loading a longer, more demanding nucleic acid |
| PEG-lipid | Low molar content | Limits oversized particles and aggregation that a large message can otherwise induce |
Short nucleic acids are compact and charge-dense, with a smaller hydrodynamic volume than mRNA. Their geometry can lead to weaker complexation, and their activity depends on rapid cytosolic availability. Early endosomal escape and stable retention of the short cargo are therefore the priorities.
| Component | Recommended Combination | Reason |
|---|---|---|
| Ionizable lipid | Tightly tuned pKa window near 6.0-6.5 | Ensures the short duplex is retained during circulation yet released quickly for cytoplasmic activity |
| Helper lipid | Fusogenic helper to drive rapid escape | Favors the early endosomal release a small guide RNA needs to reach the silencing machinery |
| Cholesterol / sterol | Standard cholesterol content | Provides a stable core without over-stabilizing the particle and slowing release |
| PEG-lipid | Low, carefully balanced content | Avoids a PEG barrier that would delay the rapid uptake and escape required for silencing |
Plasmid DNA is far larger and more supercoiled than any RNA, so efficient condensation requires a higher ionizable lipid content and a carefully optimized N/P ratio. Because a pDNA molecule carries very many negative charges, the design must also avoid over-condensation that prevents the payload from becoming available in the nucleus.
| Component | Recommended Combination | Reason |
|---|---|---|
| Ionizable lipid | Higher ionizable lipid content with a tuned N/P ratio | Provides enough charge to condense a large, highly anionic DNA molecule completely |
| Helper lipid | Helper selected to balance packing with release | Balances strong electrostatic forces against the need for the payload to leave the particle |
| Cholesterol / sterol | Content adjusted to tune bilayer curvature | Influences whether the large payload can be released for nuclear access |
| PEG-lipid | Low molar content | Prevents the particle from growing too large for efficient cellular and nuclear delivery |
Proteins and peptides lack the reproducible negative charge that nucleic acids use to drive self-assembly, so encapsulation relies on interfacial interactions, charge matching of the cargo surface, and formulation conditions that keep the protein stable and associated with the particle. Because no single rule predicts which shell retains a given protein, the lipid library is a genuine screening tool rather than a design exercise.
| Component | Recommended Combination | Reason |
|---|---|---|
| Ionizable lipid | Charge character matched to the cargo surface | Charge matching stabilizes the association between the protein and the lipid shell |
| Helper lipid | Helper lipid screened for cargo compatibility | Provides a compatible interfacial environment that keeps the protein associated and intact |
| Cholesterol / sterol | Sterol chosen to stabilize the shell | Maintains a cohesive particle without denaturing a surface-associated protein |
| PEG-lipid | Content tuned for retention versus release | Controls surface shielding and the release kinetics of a non-electrostatically bound cargo |
A hydrophobic small molecule partitions into the lipid bilayer rather than forming an electrostatic complex, so its retention depends on lipid solubility and membrane composition. When two payloads must be co-delivered, such as a nucleic acid and a hydrophobic drug, competitive loading becomes the central challenge, and the lipid composition must balance two different partitioning equilibria.
| Component | Recommended Combination | Reason |
|---|---|---|
| Ionizable lipid | Hydrophobic tails chosen to solubilize the drug | The logP of the drug dictates which lipid environment best holds it in the bilayer |
| Helper lipid | Helper that preserves cargo-carrying capacity | Affects how much hydrophobic drug the bilayer can partition while staying stable |
| Cholesterol / sterol | Content that maintains a cohesive bilayer | Prevents a high drug load from destabilizing the membrane or displacing the second cargo |
| PEG-lipid | Content balanced for both cargos | Keeps the particle size and surface appropriate while both cargos are retained at the target ratio |
A library is only as informative as the measurements used to rank it. The readouts that matter form a logical cascade, from the physical properties of the particle, through loading and protection of the payload, to the biological outcome in cells. Applying the same protocols to every library member is what turns a collection of lipids into a decision-support tool.
Hydrodynamic diameter: measured by dynamic light scattering to confirm the particle assembled in the intended size range, typically below about 150 nm for most payloads, because size strongly influences cellular uptake and biodistribution.
Polydispersity index: reported by the same measurement to indicate population uniformity, and a value below about 0.2 is generally considered evidence of a monodisperse, reproducible particle.
Zeta potential: measured by electrophoretic light scattering to report the effective surface charge, which should be near-neutral or slightly negative at physiological pH for nucleic acid LNPs to limit nonspecific interactions with serum proteins.
Morphology: assessed by imaging techniques to confirm the particle has the expected internal structure rather than a distorted, porous, or aggregated one, because a well-formed particle is a prerequisite for reliable later measurements.
Encapsulation efficiency: measured by separating free from encapsulated cargo and quantifying each, and a high fraction, often above 80-90% for nucleic acids, indicates that the payload is protected inside the particle rather than lost to the surrounding buffer.
Loading capacity: calculated as the amount of cargo carried per unit of lipid, and the optimal value balances a high therapeutic dose per particle against the risk that over-loading destabilizes the particle or causes premature leakage.
Recovery: determined by comparing the total mass of payload after formulation and purification to the input amount, and a high recovery confirms that neither the process nor the purification steps destroyed or discarded a large fraction of the cargo.
Payload integrity: assessed by size-separation or integrity assays to confirm that nucleic acids remain full-length and proteins retain their native structure, because a protected but damaged cargo cannot function.
Cargo retention: measured by tracking the encapsulated fraction over time, and a stable encapsulated content during storage indicates that the payload is not leaking from the particle.
Leakage: quantified by monitoring free payload in the surrounding medium, and minimal leakage under storage-relevant conditions is the target because premature release reduces the dose that reaches the target.
Stability: evaluated through time-course and serum-exposure studies, and an optimal candidate maintains its size, encapsulated content, and cargo integrity both on storage and in the presence of serum proteins and enzymes.
Cellular uptake: measured by quantifying how much payload or label enters the cell, and a high uptake is necessary but not sufficient, because internalized cargo can still be trapped and degraded.
Endosomal escape: evaluated with assays that distinguish cargo released into the cytosol from cargo retained in degradative endosomes, and efficient escape is the decisive step for payloads that act in the cytoplasm or nucleus.
Intracellular localization: determined by imaging or fractionation to show where the cargo accumulates, and optimal candidates deliver their payload to the compartment where it is functionally required rather than leaving it trapped.
Functional output: measured with reporter systems appropriate to the cargo, such as luciferase expression from mRNA, target-gene knockdown from siRNA, or editing efficiency from CRISPR components, because this integrates encapsulation, protection, escape, and delivery into a single biological number.
Functional ranking: used as the primary endpoint for selecting leads, and an optimal candidate shows a high functional output at a low lipid dose, which is a better indicator of true potency than a high raw signal at a saturating dose.
Readout pairing: always interpreted together with particle and loading measurements, so that a poor functional result can be traced to a specific cause rather than treated as an unexplained failure.
Cell-type selectivity: compared in an in vitro panel that includes the target cell alongside off-target cells, and an optimal candidate delivers substantially more to the intended cell type, indicating that its performance is not merely high but specific.
Biodistribution: assessed at an organism scale to confirm that the payload reaches the intended tissue, and an optimal formulation concentrates in the target compartment rather than distributing to off-target organs.
Selectivity-based ranking: applied as the final criterion when delivery to a specific site is the goal, because selectivity, rather than raw efficiency, is what distinguishes a useful lead from an efficient but non-selective one.
A large library is not automatically an informative library. If ionizable lipid, helper lipid, sterol, PEG-lipid, ratios, buffer, and mixing conditions are all changed without a structured matrix, it becomes difficult to determine why a formulation improved.
Better approach: define the primary question first, keep secondary variables controlled, and use staged or statistically structured screening when interactions need to be explored. After a lipid family is identified, process parameters can be refined through LNP process optimization instead of being mixed indiscriminately into the discovery screen.
A composition window that works for one payload can exclude the best candidates for another. Larger nucleic acids may require different complexation conditions, proteins may be sensitive to interfaces, and hydrophobic compounds may be limited by lipid-phase solubility rather than electrostatic loading.
Better approach: set screening boundaries after reviewing payload size, charge, hydrophobicity, structural sensitivity, mechanism of action, and the amount of material available. The initial library should be broad enough to reveal a trend but narrow enough that each formulation tests a plausible hypothesis.
Replacing one ionizable lipid while keeping every component ratio fixed is useful for a first comparison, but it can miss a candidate that needs a different helper-lipid, sterol, PEG-lipid, or N/P balance. Lipid identity and lipid proportion interact during self-assembly.
Better approach: use a two-stage design. First compare structurally diverse lipid candidates in one or two controlled backgrounds; then build focused ratio matrices around the best lipid families. This keeps the first screen interpretable while giving promising chemistries a fair optimization window.
Size and EE% are efficient quality filters, not proof of delivery. Published pDNA screening work has shown that formulations with similar physical features can have very different functional outcomes, reinforcing the need for staged down-selection.
Better approach: require each lead to pass a balanced scorecard that includes particle formation, payload quality, functional delivery, and the target-facing endpoint. When a formulation shows good physical properties but weak function, LNP transfection troubleshooting can help separate problems in uptake, intracellular release, payload integrity, and composition.
Building and screening a payload-specific lipid library is an intensive process that combines synthetic chemistry, formulation engineering, and a panel of analytical and functional assays. BOC Sciences offers an integrated workflow that starts from the payload and carries a project through library design, lipid preparation, parallel formulation, and physicochemical screening, so that the most promising candidates are delivered with data that supports the next development decision.
The first step is a structured assessment of the payload, including its molecular size, charge density, stability, and the intracellular or subcellular compartment where it must act. From this assessment, a screening strategy is designed that specifies the lipid structural axes to vary, the composition window to explore, and the readouts that will be used to rank candidates. This planning stage is what keeps the screen aligned with the payload, rather than with a generic formulation template.
BOC Sciences prepares the lipid materials needed for a library, whether these are established ionizable, helper, structural, or PEG-lipids or custom lipid structures synthesized to specification. For projects that require a bespoke design space, custom synthesis can supply ionizable lipids and other components with defined structure and purity, ensuring that each library member is a chemically defined, reproducible entity.
Library members are formulated in parallel and screened with consistent protocols, so that results are comparable across the whole design space. Physical characterization, payload loading, protection, and stability measurements are used to shortlist candidates, and the resulting data package provides a clear rationale for which compositions to advance. This turnkey approach lets a research team focus on the biological question while the formulation and screening mechanics are handled end to end.
The table below summarizes the services that BOC Sciences applies across a payload-specific LNP library program. Each offering can be scoped to the payload, library size, and screening depth required by the project.
| Service | Scope | Typical Deliverables | Inquiry |
|---|---|---|---|
| Custom Ionizable Lipid Synthesis | De novo or combinatorial ionizable lipids with defined head groups, linkers, and tails, prepared to specified purity and quantity | Characterized lipid lots with structural confirmation and purity data | Inquiry |
| Payload-Specific LNP Formulation | Microfluidic formulation of library members tailored to mRNA, saRNA, siRNA, pDNA, protein, peptide, or small-molecule payloads | Formulated LNP panels with size, PDI, zeta potential, and loading data | Inquiry |
| LNP Lipid Library Screening | Parallel physicochemical and functional screening across a designed lipid library | Ranked candidate list with structure-performance analysis and hit recommendations | Inquiry |
| Payload Encapsulation and Retention Testing | Encapsulation efficiency, loading capacity, recovery, integrity, and serum-stability assessment for each cargo class | Quantitative loading and protection report for screened candidates | Inquiry |
| Cellular Delivery and Functional Evaluation | Uptake, endosomal escape, intracellular localization, and cargo-specific functional readouts | Functional ranking data linking formulation to biological activity | Inquiry |
| Lead Optimization and Scale-Up | Ratio refinement, excipient screening, and transfer of lead formulations to larger, reproducible batches | Optimized lead formulation with defined process parameters and scale-up batch data | Inquiry |
A lipid library becomes a genuinely useful tool only when it is designed around the payload it is meant to carry. The four LNP components, ionizable lipids, helper lipids, cholesterol and sterol variants, and PEG-lipids, each provide independent axes that should be mapped deliberately rather than left at a default. Because mRNA, saRNA, siRNA, miRNA, ASO, pDNA, protein, peptide, small-molecule, and co-delivery payloads each engage the nanoparticle through a different mechanism, the design space must be weighted to the physicochemical demands of the specific cargo. Ranking candidates through a consistent cascade of particle formation, loading, protection, cellular delivery, and functional readouts keeps the screen aligned with the biology that actually matters. When the composition window, the experimental structure, and the ranking logic are all matched to the payload, a modest library can yield a clear and defensible lead, and BOC Sciences provides the integrated synthesis, formulation, and screening support to carry such a payload-specific program from design through candidate selection.